ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 167,50
-0,26%
Dow Jones
40 003,59
0,34%
DAX
18 704,42
-0,11%
Brent Oil
83,76
0,00%
Bitcoin
66 988,78
-0,14%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Pacific Biosciences of California Inc (PACB)

  7. Pacific Biosciences of California Inc (PACB) Actualités

PACB

Pacific Biosciences of C... (PACB)

Pacific Biosciences of California Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:PACB
DateHeureSourceTitreSymboleSociété
15/05/202415h45PR Newswire (US)Ambry Genetics and PacBio Announce Collaboration to Sequence Up to 7,000 Human Genomes Aimed at Providing Answers for Families Battling Rare DiseasesNASDAQ:PACBPacific Biosciences of California Inc
09/05/202422h33Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:PACBPacific Biosciences of California Inc
09/05/202422h21Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PACBPacific Biosciences of California Inc
09/05/202422h12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PACBPacific Biosciences of California Inc
09/05/202422h05PR Newswire (US)PacBio Announces First Quarter 2024 Financial ResultsNASDAQ:PACBPacific Biosciences of California Inc
16/04/202414h05PR Newswire (US)PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue GuidanceNASDAQ:PACBPacific Biosciences of California Inc
27/03/202413h00PR Newswire (US)Estonia National Biobank Selects PacBio to Sequence 10,000 Whole GenomesNASDAQ:PACBPacific Biosciences of California Inc
22/03/202421h30PR Newswire (US)PacBio Grants Equity Incentive Award to New EmployeeNASDAQ:PACBPacific Biosciences of California Inc
12/03/202414h05PR Newswire (US)PacBio Announces PureTarget™ Repeat Expansion Panel, Expanding its Portfolio of End-to-End Clinical Research SolutionsNASDAQ:PACBPacific Biosciences of California Inc
06/03/202423h36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PACBPacific Biosciences of California Inc
05/03/202400h32Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PACBPacific Biosciences of California Inc
26/02/202422h05PR Newswire (US)PacBio to Present at Upcoming Investor ConferencesNASDAQ:PACBPacific Biosciences of California Inc
15/02/202422h05PR Newswire (US)PacBio Announces Fourth Quarter and Fiscal Year 2023 Financial ResultsNASDAQ:PACBPacific Biosciences of California Inc
13/02/202422h15Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PACBPacific Biosciences of California Inc
13/02/202413h00PR Newswire (US)Experiential Marketing Firm VOLO Events Agency Wins Best Event Technology Award for PacBio Product LaunchNASDAQ:PACBPacific Biosciences of California Inc
05/02/202415h05PR Newswire (US)PacBio Announces HiFi Prep Kit 96 and HiFi Plex Prep Kit 96 for Long-Read Sequencing Applications at ScaleNASDAQ:PACBPacific Biosciences of California Inc
25/01/202422h03PR Newswire (US)PacBio to Report Fourth Quarter 2023 Financial Results on February 15, 2024NASDAQ:PACBPacific Biosciences of California Inc
15/01/202415h05PR Newswire (US)PacBio Announces New Nanobind PanDNA Kit Enabling HiFi Optimized DNA Extraction SolutionsNASDAQ:PACBPacific Biosciences of California Inc
08/01/202414h00PR Newswire (US)PacBio Announces Record Preliminary Fourth Quarter and Full Year Revenue Growing 113% and 56%, respectivelyNASDAQ:PACBPacific Biosciences of California Inc
27/12/202322h05PR Newswire (US)PacBio to Present at 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:PACBPacific Biosciences of California Inc
11/12/202314h00PR Newswire (US)PacBio Announces the Retirement of David Botstein, Ph.D., from its Board of DirectorsNASDAQ:PACBPacific Biosciences of California Inc
02/11/202314h05PR Newswire (US)PacBio Announces HiFi Solves, a Global Consortium of Clinical Genomics Research LeadersNASDAQ:PACBPacific Biosciences of California Inc
01/11/202314h05PR Newswire (US)PacBio Enables Rare and Inherited Disease Research by Adding Tertiary Analysis Partners to PacBio CompatibleNASDAQ:PACBPacific Biosciences of California Inc
31/10/202314h05PR Newswire (US)PacBio Announces Kinnex RNA Kits, Further Scaling HiFi Sequencing in Full-Length RNA, Single-Cell RNA and 16S rRNA ApplicationsNASDAQ:PACBPacific Biosciences of California Inc
30/10/202321h03PR Newswire (US)PacBio Announces Third Quarter 2023 Financial ResultsNASDAQ:PACBPacific Biosciences of California Inc
27/10/202323h00Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:PACBPacific Biosciences of California Inc
19/10/202322h10Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:PACBPacific Biosciences of California Inc
16/10/202314h12Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PACBPacific Biosciences of California Inc
16/10/202314h05PR Newswire (US)PacBio Announces Appointment of David Meline to Board of DirectorsNASDAQ:PACBPacific Biosciences of California Inc
12/10/202322h03PR Newswire (US)PacBio to Report Third Quarter 2023 Financial Results on October 30, 2023NASDAQ:PACBPacific Biosciences of California Inc
 Showing the most relevant articles for your search:NASDAQ:PACB

Dernières Valeurs Consultées

KOSDAQ
054620
APS
LSE
CXAU
Ubsetf Ccxaa
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés